Solid tumor chemotherapy: new drugs and horizons.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D002330:Carmustine / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008937:Mitomycins / Q000008:administration & dosage / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009607:Nitrosourea Compounds / Q000009:adverse effects / Q000627:therapeutic use; D012509:Sarcoma / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents; D007093:Imidazoles; D008937:Mitomycins; D009607:Nitrosourea Compounds; D001761:Bleomycin; D004317:Doxorubicin; D002330:Carmustine